当前位置： SCI文献检索 > JOURNAL OF PHARMACEUTICAL SCIENCES期刊下所有文献 > Myocardial effect compartment modeling of metoprolol and sotalol: importance of myocardial subsite drug concentration.

Myocardial effect compartment modeling of metoprolol and sotalol: importance of myocardial subsite drug concentration.

Abstract：

:We have recently reported the time course of acute myocardial drug uptake and simultaneous pharmacodynamic effects for metoprolol (4 mg; n = 12) and sotalol (20 mg; n = 10) in patients with ischemic heart disease. The acute pharmacodynamic effects of the two drugs included reductions in both spontaneous heart rate and the contractile index peak positive rate of left ventricular pressure rise and prolongation of the electrocardiographic PR interval, all of which exhibited an equilibration delay compared with myocardial drug content. The objective of the current study was to analyze the relationship between myocardial drug content and effect for both metoprolol and sotalol using an effect compartment model, to examine the potential for the two drugs to share a common subsite of action in the myocardium. The time course of myocardial drug content was best described by a one-compartment model for metoprolol and a two-compartment model for sotalol. A linear pharmacodynamic model, relating the amount of drug at the effect-site (Ae) with each of the three effects, was used in the effect compartment modeling. The slope of each of these effects as a function of Ae was considerably flatter for sotalol than for metoprolol, reflecting the relative beta-adrenoceptor antagonistic potencies of the two drugs. The exit rate constant from the effect compartment (K(eo)) did not differ significantly from each other or from the exit rate constant from the "peripheral" compartment (K21) for sotalol. The results suggest that the effect compartment within the myocardium for both drugs may correspond to a "peripheral" compartment, even though a "peripheral" pharmacokinetic compartment for myocardial metoprolol content was not apparent. Thus, the effect compartment for many cardioactive drugs may correspond to a pharmacokinetically "peripheral" compartment, irrespective of localization of effect to a small (e.g. sinoatrial node) or large (e.g. ventricular myocardium) region of the heart.

journal_name

J Pharm Sci

journal_title

Journal of pharmaceutical sciences

authors

Ritchie RH,Morgan DJ,Horowitz JD

doi

10.1021/js9702776

subject

Has Abstract

pub_date

1998-02-01 00:00:00

pages

177-82

issue

eissn

0022-3549

issn

1520-6017

pii

S0022-3549(15)50500-5

journal_volume

pub_type

临床试验,杂志文章

在线工具

Myocardial effect compartment modeling of metoprolol and sotalol: importance of myocardial subsite drug concentration.